Doxorubicin hydrochloride
PBRM1-BD2-IN-2
FT001
PBRM1-BD2-IN-5
c-Fms-IN-10
AAPK-25
Darbufelone mesylate
PI3K/mTOR Inhibitor-2
Zandelisib
IHMT-PI3Kδ-372
hSMG-1 inhibitor 11j
LDN-212854
N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline
Torkinib
FGFR2-IN-3
methyl 5-bromo-1H-pyrrole-2-carboxylate
1H-Pyrrole-2-carboxylic acid,4,5-dibromo-1-methyl-
5-(5-Fluoro-2-oxo-1,2-dihydro-indol-3-ylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic Acid
MIRA-1
CCR8 antagonist 1
U18666A
2-Nonylquinolin-4(1H)-one
WP1066
SEL120-34A monohydrochloride
Flurochloridone
MMAF
Maytansinol
Voreloxin Hydrochloride
Moxifloxacin hydrochloride
Flucytosine
NKP-1339
Givinostat hydrochloride
CAY10603
TIQ-A
Sapacitabine
GW0742
XMD16-5
GFT505
Soyasaponin Aa
Benzamide,3-methoxy-N-(3-thiazolo[5,4-b]pyridin-2-ylphenyl)
OSS_128167
Toll-like receptor modulator
Aminoguanidine hydrochloride
CGP60474
PKCβpseudosubstrate acetate
Moracin C
Betahistine dihydrochloride
LML134
Pitolisant hydrochloride
Loratadine
Clobenpropit dihydrobromide
H3 receptor antagonist 1
Marmin
Dihydrocucurbitacin B
K-7174
Angoline
Bornyl acetate
Compstatin control peptide acetate
Valdecoxib
Hesperin
